Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million
Go back to Biohaven and Royalty Pharma Announce Funding Agreement Totaling up to $450 Million| (NYSE: BHVN) | Delayed: 15.39 +0.67 (4.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.72 | 52 Week High | $ | |||
| Open | $14.62 | 52 Week Low | $ | |||
| Day High | $15.46 | P/E | N/A | |||
| Day Low | $14.42 | EPS | $ | |||
| Volume | 1,847,892 | |||||
| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 60.42 -0.17 (0.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.59 | 52 Week High | $3.48 | |||
| Open | $60.60 | 52 Week Low | $0.80 | |||
| Day High | $60.80 | P/E | N/A | |||
| Day Low | $59.31 | EPS | $-1.54 | |||
| Volume | 2,681,383 | |||||
